BarbaraBresnahanMD

PubMed

• Outcomes at 7 years post-transplant in black versus non-black kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT.
  Florman, S.,Vincenti, F.,Durrbach, A.,Abouljoud, M.,Bresnahan, B.,Garcia, V. D.,Mulloy, L.,Rice, K.,Rostaing, L.,Zayas, C.,Calderon, K.,Meier-Kriesche, U.,Polinsky, M....> ;Clin Transplant. 2018 Feb 21
• Large Granular Lymphocytic Leukemia Presenting Late After Solid Organ Transplantation: A Case Series of Four Patients and Review of the Literature.
  Kataria, A.,Cohen, E.,Saad, E.,Atallah, E.,Bresnahan, B.> ;Transplant. Proc.. 2014 Sep 23
• Belatacept-versus Cyclosporine-Based Immunosuppression in Renal Transplant Recipients with Pre-existing Diabetes
  Lionel Rostaing, Hans H. Neumayer, Rafael Reyes-Acevedo, Barbara A. Bresnahan, Sander Florman, Stefan Vitko, Michael Heifets, Jun Xing, Dolca Thomas, Flavio Vincenti> ;Clinical Journal of The American Society of Nephrology. 2011 Nov 1
• Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.
  Ehab R. Saad, Barbara A. Bresnahan, Eric P. Cohen, Na Lu, Rimas J. Orentas, Brahm Vasudev, Sundaram Hariharan> ;Transplantation. 2008 Mar 27
• 14 citations
  A comparison between recipients receiving matched kidney and those receiving mismatched kidney from the same cadaver donor.
  Barbara A. Bresnahan, Christopher P. Johnson, Matthew McIntosh, Donald Stablein, Sundaram Hariharan> ;American Journal of Transplantation. 2002 Apr 1
• Eicosanoid-induced growth and signaling events in rat glomerular mesangial cells.
  D. Kelefiotis, Barbara A. Bresnahan, I. Stratidakis, Elias A. Lianos> ;Prostaglandins. 1995 May 1
• Mesangial cell immune injury. Hemodynamic role of leukocyte- and platelet-derived eicosanoids.
  Barbara A. Bresnahan, Sheng-Hua Wu, F. J. Fenoy, Richard J. Roman, Elias A. Lianos> ;Journal of Clinical Investigation. 1992 Dec 1
• Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.
  Vincenti, F., Larsen, C. P., Alberu, J., Bresnahan, B., Garcia, V. D., Kothari, J., Lang, P., Urrea, E. M., Massari, P., Mondragon-Ramirez, G., Reyes-Acevedo, R., Rice...> ;Am J Transplant. 2012 Jan
• Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT an...
  Vanrenterghem, Y., Bresnahan, B., Campistol, J., Durrbach, A., Grinyó, J., Neumayer, H. H., Lang, P., Larsen, C. P., Mancilla-Urrea, E., Pestana, J. M., Block, A., Dua...> ;Transplantation. 2011 May 15
• A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
  Vincenti, F., Charpentier, B., Vanrenterghem, Y., Rostaing, L., Bresnahan, B., Darji, P., Massari, P., Mondragon-Ramirez, G. A., Agarwal, M., Di Russo, G., Lin, C. S.,...> ;Am J Transplant. 2010 Mar
• Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.
  Cibrik, D., Meier-Kriesche, H. U., Bresnahan, B., Wu, Y. M., Klintmalm, G., Kew, C. E., Kuo, P. C., Whelchel, J., Cohen, D., Baliga, P., Akalin, E., Benedetti, E., Wri...> ;Clin Transplant. 2007 Apr 12
• Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
  Khanna, A., Plummer, M., Bromberek, C., Bresnahan, B., Hariharan, S.> ;Kidney Int. 2002 Dec
• Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis.
  Ahuja, M., Cohen, E. P., Dayer, A. M., Kampalath, B., Chang, C. C., Bresnahan, B. A., Hariharan, S.> ;Transplantation. 2001 Apr 15
• Improved graft survival after renal transplantation in the United States, 1988 to 1996.
  Hariharan, S., Johnson, C. P., Bresnahan, B. A., Taranto, S. E., McIntosh, M. J., Stablein, D.> ;N Engl J Med. 2000 Mar 2
• Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury.
  Lianos, E. A., Bresnahan, B. A.> ;J Lab Clin Med. 1999 Nov
• Changes in glomerular thromboxane A2 receptor expression and ligand binding following immune injury.
  Bresnahan, B. A., Dufek, S., Wu, S., Lianos, E. A.> ;Kidney Int. 1999 Jan
• Cytokine inhibition preserves renal hemodynamic function following mesangial cell immune injury.
  Pan, C. G., Bresnahan, B. A., Albrightson, C. R., Griswold, D., Lianos, E. A.> ;J Investig Med. 1996 Aug
• Localization of authentic thromboxane A2/prostaglandin H2 receptor in the rat kidney.
  Bresnahan, B. A., Le Breton, G. C., Lianos, E. A.> ;Kidney Int. 1996 May
• Hemodynamic role of arachidonate 12- and 5-lipoxygenases in nephrotoxic serum nephritis.
  Wu, S. H., Bresnahan, B. A., Lianos, E. A.> ;Kidney Int. 1993 Jun
• Mesangial cell immune injury: effects of thromboxane receptor antagonism.
  Bresnahan, B. A., Roman, R. J., Bagchus, W. M., Lianos, E. A.> ;J Am Soc Nephrol. 1991 Feb
• Mesangial cell immune injury. Synthesis, origin, and role of eicosanoids.
  Lianos, E. A., Bresnahan, B. A., Pan, C.> ;J Clin Invest. 1991 Aug
• Lower Prevalence of BK Virus Infection in African American Renal Transplant Recipients: A Prospective Study.
  Sood, P., Senanayake, S., Sujeet, K., Medipalli, R., Saad, E., Vasudev, B., Bresnahan, B. A., Johnson, C. P., Hariharan, S.> ;Transplantation. 2012 Feb 15
• Percussion hemoglobinuria - a novel term for hand trauma-induced mechanical hemolysis: a case report.
  Vasudev, M., Bresnahan, B. A., Cohen, E. P., Hari, P. N., Hariharan, S., Vasudev, B. S.> ;J Med Case Reports. 2011
• BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
  Vasudev, B., Hariharan, S., Hussain, S. A., Zhu, Y. R., Bresnahan, B. A., Cohen, E. P.> ;Kidney Int. 2005 Oct
• Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
  Ganne, V., Siddiqi, N., Kamaplath, B., Chang, C. C., Cohen, E. P., Bresnahan, B. A., Hariharan, S.> ;Clin Transplant. 2003 Oct
• Join now to see all